Montréal, QC August 22, 2014: In a move that will benefit millions of people with diabetes, 9 of the largest health insurers in Canada have approved Timesulin as a reimbursable product.
This is an exciting decision for the diabetes community as the cost of managing diabetes has increased tremendously over the last few decades, making it difficult for everyone to have access to important, life-saving technology and healthcare. By making the Timesulin insulin pen replacement cap reimbursable, Canada is helping lead the charge to reduce the health and economic consequences of diabetes and ensure more peace of mind for everyone living with diabetes.
The insurance companies that have approved Timesulin for reimbursement include:
- Great West Life
- Manulife Financial
- Sun Life Financial
- Industrial Alliances
- Medavie Blue Cross
- Empire Life
- Standard Life
- Equitable Life
Timesulin is a simple solution to a very common problem for people with diabetes. An accidental double dose and missed dose can lead to serious complications and hypoglycemic episodes. Timesulin helps reduce the possibility of these complications, by giving users more peace of mind and control over their healthcare.
Created as a way to ease the anxiety of remembering when his last insulin shot was, John Sjölund created Timesulin to solve a problem that wasn’t being addressed by any of the larger diabetes companies. The smart replacement cap is compatible with all major disposable insulin pens, and has an incorporated timer to show users how long it’s been since their last injection.
“This is a huge step in the right direction, though we still have a long way to go to help make diabetes care equal and more accessible to everyone.” John Sjölund, CEO of Timesulin.
Timesulin’s partner in Canada, Montméd, is a manufacturer and distributor of medical devices within the diabetes and self-care area. They’re range of products include pen needles, insulin syringes, thermometers, blood pressure monitors, skin care, insulin cooling wallets, and other devices.
“This is a matter of equality. Public healthcare coverage in Canada is uneven because decisions are made within the provinces and territories. We want to be able to provide the same accessibility to everyone living with diabetes – no matter what insurance provider they have.” Gino Henry, General Manager of Montméd for Canada.
Phone: +46 (0)735151320
Email: [email protected]
Notes for Editors:
- Hi-res images available
- Available for quotes and interviews with John Sjölund, CEO and other diabetes specialists familiar with Timesulin